SOCS3

References

• Kiu H, Nicholson SE. Biology and significance of the JAK/STAT signalling pathways. Growth Factors 2012; 30:88 - 106; http://dx.doi.org/10.3109/08977194.2012.660936; PMID: 22339650
   PubMed Web of Science ®Google Scholar
• Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178:2623 - 9; PMID: 17312100
   PubMed Web of Science ®Google Scholar
• Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387:917 - 21; http://dx.doi.org/10.1038/43206; PMID: 9202125
   PubMed Web of Science ®Google Scholar
• Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387:921 - 4; http://dx.doi.org/10.1038/43213; PMID: 9202126
   PubMed Web of Science ®Google Scholar
• Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387:924 - 9; http://dx.doi.org/10.1038/43219; PMID: 9202127
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995; 14:2816 - 26; PMID: 7796808
   PubMed Web of Science ®Google Scholar
• Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A 1998; 95:114 - 9; http://dx.doi.org/10.1073/pnas.95.1.114; PMID: 9419338
   PubMed Web of Science ®Google Scholar
• Babon JJ, McManus EJ, Yao S, DeSouza DP, Mielke LA, Sprigg NS, et al. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. Mol Cell 2006; 22:205 - 16; http://dx.doi.org/10.1016/j.molcel.2006.03.024; PMID: 16630890
   PubMed Web of Science ®Google Scholar
• Babon JJ, Nicola NA. The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors 2012; 30:207 - 19; http://dx.doi.org/10.3109/08977194.2012.687375; PMID: 22574771
   PubMed Web of Science ®Google Scholar
• Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, et al. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 1999; 4:339 - 51; http://dx.doi.org/10.1046/j.1365-2443.1999.00263.x; PMID: 10421843
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999; 18:1309 - 20; http://dx.doi.org/10.1093/emboj/18.5.1309; PMID: 10064597
   PubMed Web of Science ®Google Scholar
• Bergamin E, Wu J, Hubbard SR. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. Structure 2006; 14:1285 - 92; http://dx.doi.org/10.1016/j.str.2006.06.011; PMID: 16905102
   PubMed Web of Science ®Google Scholar
• Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, Young SN, et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 2012; 36:239 - 50; http://dx.doi.org/10.1016/j.immuni.2011.12.015; PMID: 22342841
   PubMed Web of Science ®Google Scholar
• Nicholson SE, De Souza D, Fabri LJ, Corbin J, Willson TA, Zhang JG, et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A 2000; 97:6493 - 8; http://dx.doi.org/10.1073/pnas.100135197; PMID: 10829066
   PubMed Web of Science ®Google Scholar
• De Souza D, Fabri LJ, Nash A, Hilton DJ, Nicola NA, Baca M. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 2002; 41:9229 - 36; http://dx.doi.org/10.1021/bi0259507; PMID: 12119038
   PubMed Web of Science ®Google Scholar
• Hörtner M, Nielsch U, Mayr LM, Johnston JA, Heinrich PC, Haan S. Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol 2002; 169:1219 - 27; PMID: 12133942
   PubMed Web of Science ®Google Scholar
• Dunn SL, Björnholm M, Bates SH, Chen Z, Seifert M, Myers MG Jr.. Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. Mol Endocrinol 2005; 19:925 - 38; http://dx.doi.org/10.1210/me.2004-0353; PMID: 15604114
   PubMed Web of Science ®Google Scholar
• Hörtner M, Nielsch U, Mayr LM, Heinrich PC, Haan S. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Eur J Biochem 2002; 269:2516 - 26; http://dx.doi.org/10.1046/j.1432-1033.2002.02916.x; PMID: 12027890
   PubMedGoogle Scholar
• Yamamoto K, Yamaguchi M, Miyasaka N, Miura O. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. Biochem Biophys Res Commun 2003; 310:1188 - 93; http://dx.doi.org/10.1016/j.bbrc.2003.09.140; PMID: 14559241
   PubMed Web of Science ®Google Scholar
• Ram PA, Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 1999; 274:35553 - 61; http://dx.doi.org/10.1074/jbc.274.50.35553; PMID: 10585430
   PubMed Web of Science ®Google Scholar
• Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 2000; 275:15985 - 91; http://dx.doi.org/10.1074/jbc.275.21.15985; PMID: 10821852
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 2003; 4:551 - 6; http://dx.doi.org/10.1038/ni938; PMID: 12754507
   PubMed Web of Science ®Google Scholar
• Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996; 5:449 - 60; http://dx.doi.org/10.1016/S1074-7613(00)80501-4; PMID: 8934572
   PubMed Web of Science ®Google Scholar
• Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, Whitlock EL, et al. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol 2013; 20:469 - 76; http://dx.doi.org/10.1038/nsmb.2519; PMID: 23454976
   PubMed Web of Science ®Google Scholar
• Babon JJ, Yao S, DeSouza DP, Harrison CF, Fabri LJ, Liepinsh E, et al. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain. FEBS J 2005; 272:6120 - 30; http://dx.doi.org/10.1111/j.1742-4658.2005.05010.x; PMID: 16302975
   PubMed Web of Science ®Google Scholar
• Linossi EM, Nicholson SE. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life 2012; 64:316 - 23; http://dx.doi.org/10.1002/iub.1011; PMID: 22362562
   PubMed Web of Science ®Google Scholar
• Babon JJ, Sabo JK, Soetopo A, Yao S, Bailey MF, Zhang JG, et al. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J Mol Biol 2008; 381:928 - 40; http://dx.doi.org/10.1016/j.jmb.2008.06.038; PMID: 18590740
   PubMed Web of Science ®Google Scholar
• Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, Conaway RC, et al. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 2004; 18:3055 - 65; http://dx.doi.org/10.1101/gad.1252404; PMID: 15601820
   PubMed Web of Science ®Google Scholar
• Babon JJ, Sabo JK, Zhang JG, Nicola NA, Norton RS. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. J Mol Biol 2009; 387:162 - 74; http://dx.doi.org/10.1016/j.jmb.2009.01.024; PMID: 19385048
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165:1499 - 508; http://dx.doi.org/10.1016/S0002-9440(10)63408-6; PMID: 15509521
   PubMed Web of Science ®Google Scholar
• Orr SJ, Morgan NM, Elliott J, Burrows JF, Scott CJ, McVicar DW, et al. CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. Blood 2007; 109:1061 - 8; http://dx.doi.org/10.1182/blood-2006-05-023556; PMID: 17008544
   PubMed Web of Science ®Google Scholar
• Orr SJ, Morgan NM, Buick RJ, Boyd CR, Elliott J, Burrows JF, et al. SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J Biol Chem 2007; 282:3418 - 22; http://dx.doi.org/10.1074/jbc.C600216200; PMID: 17138568
   PubMed Web of Science ®Google Scholar
• Orabona C, Pallotta MT, Volpi C, Fallarino F, Vacca C, Bianchi R, et al. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc Natl Acad Sci U S A 2008; 105:20828 - 33; http://dx.doi.org/10.1073/pnas.0810278105; PMID: 19088199
   PubMed Web of Science ®Google Scholar
• Liu E, Côté JF, Vuori K. Negative regulation of FAK signaling by SOCS proteins. EMBO J 2003; 22:5036 - 46; http://dx.doi.org/10.1093/emboj/cdg503; PMID: 14517242
   PubMed Web of Science ®Google Scholar
• Le Y, Zhu BM, Harley B, Park SY, Kobayashi T, Manis JP, et al. SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis. Immunity 2007; 27:811 - 23; http://dx.doi.org/10.1016/j.immuni.2007.09.011; PMID: 18031698
   PubMed Web of Science ®Google Scholar
• Irandoust MI, Aarts LH, Roovers O, Gits J, Erkeland SJ, Touw IP. Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J 2007; 26:1782 - 93; http://dx.doi.org/10.1038/sj.emboj.7601640; PMID: 17363902
   PubMed Web of Science ®Google Scholar
• Wölfler A, Irandoust M, Meenhuis A, Gits J, Roovers O, Touw IP. Site-specific ubiquitination determines lysosomal sorting and signal attenuation of the granulocyte colony-stimulating factor receptor. Traffic 2009; 10:1168 - 79; http://dx.doi.org/10.1111/j.1600-0854.2009.00928.x; PMID: 19453968
   PubMed Web of Science ®Google Scholar
• Boyle K, Zhang JG, Nicholson SE, Trounson E, Babon JJ, McManus EJ, et al. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal 2009; 21:394 - 404; http://dx.doi.org/10.1016/j.cellsig.2008.11.002; PMID: 19056487
   PubMed Web of Science ®Google Scholar
• Williams JJ, Palmer TM. Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3. Biochem Soc Trans 2012; 40:215 - 8; http://dx.doi.org/10.1042/BST20110629; PMID: 22260693
   PubMed Web of Science ®Google Scholar
• van de Geijn GJ, Gits J, Touw IP. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol 2004; 76:237 - 44; http://dx.doi.org/10.1189/jlb.0104041; PMID: 15107455
   PubMed Web of Science ®Google Scholar
• van de Geijn GJ, Gits J, Aarts LH, Heijmans-Antonissen C, Touw IP. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood 2004; 104:667 - 74; http://dx.doi.org/10.1182/blood-2003-08-2913; PMID: 15069015
   PubMed Web of Science ®Google Scholar
• Auernhammer CJ, Bousquet C, Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A 1999; 96:6964 - 9; http://dx.doi.org/10.1073/pnas.96.12.6964; PMID: 10359822
   PubMed Web of Science ®Google Scholar
• Ehlting C, Häussinger D, Bode JG. Sp3 is involved in the regulation of SOCS3 gene expression. Biochem J 2005; 387:737 - 45; http://dx.doi.org/10.1042/BJ20041101; PMID: 15554904
   PubMed Web of Science ®Google Scholar
• Ehlting C, Lai WS, Schaper F, Brenndörfer ED, Matthes RJ, Heinrich PC, et al. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J Immunol 2007; 178:2813 - 26; PMID: 17312125
   PubMed Web of Science ®Google Scholar
• Kiu H, Hilton DJ, Nicola NA, Ernst M, Marquez R, Alexander WS, et al. Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFalpha. Growth Factors 2007; 25:319 - 28; http://dx.doi.org/10.1080/08977190701830151; PMID: 18236210
   PubMed Web of Science ®Google Scholar
• Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, Benveniste EN. Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J Immunol 2007; 179:5966 - 76; PMID: 17947670
   PubMed Web of Science ®Google Scholar
• Barclay JL, Anderson ST, Waters MJ, Curlewis JD. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. Mol Endocrinol 2007; 21:2503 - 15; http://dx.doi.org/10.1210/me.2006-0498; PMID: 17609438
   PubMed Web of Science ®Google Scholar
• Sands WA, Woolson HD, Milne GR, Rutherford C, Palmer TM. Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol Cell Biol 2006; 26:6333 - 46; http://dx.doi.org/10.1128/MCB.00207-06; PMID: 16914720
   PubMed Web of Science ®Google Scholar
• Yarwood SJ, Borland G, Sands WA, Palmer TM. Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene. J Biol Chem 2008; 283:6843 - 53; http://dx.doi.org/10.1074/jbc.M710342200; PMID: 18195020
   PubMed Web of Science ®Google Scholar
• Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1:619 - 25; http://dx.doi.org/10.1016/S1097-2765(00)80062-3; PMID: 9660946
   PubMed Web of Science ®Google Scholar
• Gatto L, Berlato C, Poli V, Tininini S, Kinjyo I, Yoshimura A, et al. Analysis of SOCS-3 promoter responses to interferon gamma. J Biol Chem 2004; 279:13746 - 54; http://dx.doi.org/10.1074/jbc.M308999200; PMID: 14742442
   PubMed Web of Science ®Google Scholar
• Wong PK, Egan PJ, Croker BA, O’Donnell K, Sims NA, Drake S, et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest 2006; 116:1571 - 81; http://dx.doi.org/10.1172/JCI25660; PMID: 16710471
   PubMed Web of Science ®Google Scholar
• Lejeune D, Demoulin JB, Renauld JC. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. Biochem J 2001; 353:109 - 16; http://dx.doi.org/10.1042/0264-6021:3530109; PMID: 11115404
   PubMed Web of Science ®Google Scholar
• Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, et al. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 1999; 94:2880 - 9; PMID: 10515892
   PubMed Web of Science ®Google Scholar
• Jones SA, White CA, Robb L, Alexander WS, Tarlinton DM. SOCS3 deletion in B cells alters cytokine responses and germinal center output. J Immunol 2011; 187:6318 - 26; http://dx.doi.org/10.4049/jimmunol.1102057; PMID: 22075701
   PubMed Web of Science ®Google Scholar
• Jegalian AG, Wu H. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J Biol Chem 2002; 277:2345 - 52; http://dx.doi.org/10.1074/jbc.M105575200; PMID: 11696536
   PubMed Web of Science ®Google Scholar
• Ma Z, Gong Y, Patel V, Karner CM, Fischer E, Hiesberger T, et al. Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3. Proc Natl Acad Sci U S A 2007; 104:20386 - 91; http://dx.doi.org/10.1073/pnas.0705957104; PMID: 18077349
   PubMed Web of Science ®Google Scholar
• Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, et al. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 2009; 183:97 - 105; http://dx.doi.org/10.4049/jimmunol.0801986; PMID: 19535626
   PubMed Web of Science ®Google Scholar
• Haan S, Ferguson P, Sommer U, Hiremath M, McVicar DW, Heinrich PC, et al. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J Biol Chem 2003; 278:31972 - 9; http://dx.doi.org/10.1074/jbc.M303170200; PMID: 12783885
   PubMed Web of Science ®Google Scholar
• Sasaki A, Inagaki-Ohara K, Yoshida T, Yamanaka A, Sasaki M, Yasukawa H, et al. The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6. J Biol Chem 2003; 278:2432 - 6; http://dx.doi.org/10.1074/jbc.C200608200; PMID: 12459551
   PubMed Web of Science ®Google Scholar
• Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 1999; 96:2071 - 6; http://dx.doi.org/10.1073/pnas.96.5.2071; PMID: 10051596
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Elliott J, Barry AC, Hibbert L, Cacalano NA, Johnston JA. SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol Cell Biol 2005; 25:9115 - 26; http://dx.doi.org/10.1128/MCB.25.20.9115-9126.2005; PMID: 16199887
   PubMed Web of Science ®Google Scholar
• Piessevaux J, Lavens D, Montoye T, Wauman J, Catteeuw D, Vandekerckhove J, et al. Functional cross-modulation between SOCS proteins can stimulate cytokine signaling. J Biol Chem 2006; 281:32953 - 66; http://dx.doi.org/10.1074/jbc.M600776200; PMID: 16956890
   PubMed Web of Science ®Google Scholar
• Kiu H, Greenhalgh CJ, Thaus A, Hilton DJ, Nicola NA, Alexander WS, et al. Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2. Growth Factors 2009; 27:384 - 93; http://dx.doi.org/10.3109/08977190903210954; PMID: 19919527
   PubMed Web of Science ®Google Scholar
• Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A 2001; 98:9324 - 9; http://dx.doi.org/10.1073/pnas.161271798; PMID: 11481489
   PubMed Web of Science ®Google Scholar
• Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 1999; 98:617 - 27; http://dx.doi.org/10.1016/S0092-8674(00)80049-5; PMID: 10490101
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, Ihle JN. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 2003; 22:372 - 84; http://dx.doi.org/10.1093/emboj/cdg057; PMID: 12554639
   PubMed Web of Science ®Google Scholar
• Yajima T, Murofushi Y, Zhou H, Park S, Housman J, Zhong ZH, et al. Absence of SOCS3 in the cardiomyocyte increases mortality in a gp130-dependent manner accompanied by contractile dysfunction and ventricular arrhythmias. Circulation 2011; 124:2690 - 701; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.028498; PMID: 22082679
   PubMed Web of Science ®Google Scholar
• Robb L, Boyle K, Rakar S, Hartley L, Lochland J, Roberts AW, et al. Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease. Proc Natl Acad Sci U S A 2005; 102:16333 - 8; http://dx.doi.org/10.1073/pnas.0508023102; PMID: 16258063
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Dominici M, Swift J, Nagy C, Ihle JN. Trophoblast stem cells rescue placental defect in SOCS3-deficient mice. J Biol Chem 2006; 281:11444 - 5; http://dx.doi.org/10.1074/jbc.C600015200; PMID: 16517610
   PubMed Web of Science ®Google Scholar
• Forrai A, Boyle K, Hart AH, Hartley L, Rakar S, Willson TA, et al. Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells. Stem Cells 2006; 24:604 - 14; http://dx.doi.org/10.1634/stemcells.2005-0323; PMID: 16123385
   PubMed Web of Science ®Google Scholar
• Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 2004; 23:7150 - 60; http://dx.doi.org/10.1038/sj.onc.1207930; PMID: 15378075
   PubMed Web of Science ®Google Scholar
• Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 2003; 4:540 - 5; http://dx.doi.org/10.1038/ni931; PMID: 12754505
   PubMed Web of Science ®Google Scholar
• Lang R, Pauleau AL, Parganas E, Takahashi Y, Mages J, Ihle JN, et al. SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 2003; 4:546 - 50; http://dx.doi.org/10.1038/ni932; PMID: 12754506
   PubMed Web of Science ®Google Scholar
• Kimura A, Kinjyo I, Matsumura Y, Mori H, Mashima R, Harada M, et al. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J Biol Chem 2004; 279:6905 - 10; http://dx.doi.org/10.1074/jbc.C300496200; PMID: 14699146
   PubMed Web of Science ®Google Scholar
• Whitmarsh RJ, Gray CM, Gregg B, Christian DA, May MJ, Murray PJ, et al. A critical role for SOCS3 in innate resistance to Toxoplasma gondii. Cell Host Microbe 2011; 10:224 - 36; http://dx.doi.org/10.1016/j.chom.2011.07.009; PMID: 21925110
   PubMed Web of Science ®Google Scholar
• Hiwatashi K, Tamiya T, Hasegawa E, Fukaya T, Hashimoto M, Kakoi K, et al. Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction. Cancer Lett 2011; 308:172 - 80; http://dx.doi.org/10.1016/j.canlet.2011.04.024; PMID: 21624767
   PubMed Web of Science ®Google Scholar
• Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 2006; 25:2520 - 30; http://dx.doi.org/10.1038/sj.onc.1209281; PMID: 16474852
   PubMed Web of Science ®Google Scholar
• Croker BA, Metcalf D, Robb L, Wei W, Mifsud S, DiRago L, et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004; 20:153 - 65; http://dx.doi.org/10.1016/S1074-7613(04)00022-6; PMID: 14975238
   PubMed Web of Science ®Google Scholar
• Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001; 108:1781 - 8; PMID: 11748261
   PubMed Web of Science ®Google Scholar
• Croker BA, Kiu H, Pellegrini M, Toe J, Preston S, Metcalf D, et al. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. Immunol Cell Biol 2012; 90:124 - 9; http://dx.doi.org/10.1038/icb.2011.29; PMID: 21519345
   PubMed Web of Science ®Google Scholar
• Boyle K, Egan P, Rakar S, Willson TA, Wicks IP, Metcalf D, et al. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 2007; 110:1466 - 74; http://dx.doi.org/10.1182/blood-2007-03-079178; PMID: 17510322
   PubMed Web of Science ®Google Scholar
• Zhu BM, Ishida Y, Robinson GW, Pacher-Zavisin M, Yoshimura A, Murphy PM, et al. SOCS3 negatively regulates the gp130-STAT3 pathway in mouse skin wound healing. J Invest Dermatol 2008; 128:1821 - 9; http://dx.doi.org/10.1038/sj.jid.5701224; PMID: 18185532
   PubMed Web of Science ®Google Scholar
• Sutherland KD, Vaillant F, Alexander WS, Wintermantel TM, Forrest NC, Holroyd SL, et al. c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO J 2006; 25:5805 - 15; http://dx.doi.org/10.1038/sj.emboj.7601455; PMID: 17139252
   PubMed Web of Science ®Google Scholar
• Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, Hatton CJ, et al. SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood 2012; 120:2925 - 9; http://dx.doi.org/10.1182/blood-2012-04-422527; PMID: 22791286
   PubMed Web of Science ®Google Scholar
• Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008; 118:1727 - 38; PMID: 18431520
   PubMed Web of Science ®Google Scholar
• Rigby RJ, Simmons JG, Greenhalgh CJ, Alexander WS, Lund PK. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene 2007; 26:4833 - 41; http://dx.doi.org/10.1038/sj.onc.1210286; PMID: 17297444
   PubMed Web of Science ®Google Scholar
• Inagaki-Ohara K, Mayuzumi H, Kato S, Minokoshi Y, Otsubo T, Kawamura YI, et al. Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice. Oncogene 2012; In press http://dx.doi.org/10.1038/onc.2012.540; PMID: 23178499
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Kobayashi T, Ichiyama K, Yoshida R, Hashimoto M, Takimoto T, et al. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol 2007; 179:2170 - 9; PMID: 17675476
   PubMed Web of Science ®Google Scholar
• Pillemer BB, Xu H, Oriss TB, Qi Z, Ray A. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function. Eur J Immunol 2007; 37:2082 - 9; http://dx.doi.org/10.1002/eji.200737193; PMID: 17621372
   PubMed Web of Science ®Google Scholar
• Li Y, Chu N, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 2006; 177:1679 - 88; PMID: 16849477
   PubMed Web of Science ®Google Scholar
• Nakaya M, Hashimoto M, Nakagawa R, Wakabayashi Y, Ishizaki T, Takada I, et al. SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis. J Immunol 2009; 183:7047 - 53; http://dx.doi.org/10.4049/jimmunol.0900547; PMID: 19915050
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol 2002; 168:3181 - 7; PMID: 11907070
   PubMed Web of Science ®Google Scholar
• Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, et al. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med 2003; 9:1047 - 54; http://dx.doi.org/10.1038/nm896; PMID: 12847520
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Seki Y, Watanabe R, Hayashi K, Johnston JA, Harada Y, et al. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J Exp Med 2003; 197:425 - 36; http://dx.doi.org/10.1084/jem.20020939; PMID: 12591901
   PubMed Web of Science ®Google Scholar
• Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 2006; 203:1021 - 31; http://dx.doi.org/10.1084/jem.20052333; PMID: 16606674
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Calzascia T, Toe JG, Preston SP, Lin AE, Elford AR, et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011; 144:601 - 13; http://dx.doi.org/10.1016/j.cell.2011.01.011; PMID: 21295337
   PubMed Web of Science ®Google Scholar
• Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A 2006; 103:8137 - 42; http://dx.doi.org/10.1073/pnas.0600666103; PMID: 16698929
   PubMed Web of Science ®Google Scholar
• Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001; 10:545 - 53; http://dx.doi.org/10.1023/A:1013063514007; PMID: 11817542
   PubMed Web of Science ®Google Scholar
• Takahama Y, Ohishi K, Tokoro Y, Sugawara T, Yoshimura Y, Okabe M, et al. Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. Eur J Immunol 1998; 28:2159 - 66; http://dx.doi.org/10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; PMID: 9692885
   PubMed Web of Science ®Google Scholar
• Romain M, Taleb S, Dalloz M, Ponnuswamy P, Esposito B, Pérez N, et al. Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice--brief report. Arterioscler Thromb Vasc Biol 2013; 33:581 - 4; http://dx.doi.org/10.1161/ATVBAHA.112.300516; PMID: 23329138
   PubMed Web of Science ®Google Scholar
• Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332:83 - 5; http://dx.doi.org/10.1038/332083a0; PMID: 3258060
   PubMed Web of Science ®Google Scholar
• Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000; 19:2496 - 504; http://dx.doi.org/10.1038/sj.onc.1203486; PMID: 10851048
   PubMed Web of Science ®Google Scholar
• Percy MJ, McMullin MF. The V617F JAK2 mutation and the myeloproliferative disorders. Hematol Oncol 2005; 23:91 - 3; http://dx.doi.org/10.1002/hon.761; PMID: 16285006
   PubMed Web of Science ®Google Scholar
• Vanasse GJ, Winn RK, Rodov S, Zieske AW, Li JT, Tupper JC, et al. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Mol Cancer Res 2004; 2:620 - 31; PMID: 15561778
   PubMed Web of Science ®Google Scholar
• Liang P, Cheng SH, Cheng CK, Lau KM, Lin SY, Chow EY, et al. Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma. Haematologica 2013; 98:288 - 95; http://dx.doi.org/10.3324/haematol.2012.065607; PMID: 22929979
   PubMed Web of Science ®Google Scholar
• Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 2008; 19:414 - 22; http://dx.doi.org/10.1016/j.semcdb.2008.07.010; PMID: 18708154
   PubMed Web of Science ®Google Scholar
• Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 2004; 10:739 - 43; http://dx.doi.org/10.1038/nm1071; PMID: 15208705
   PubMed Web of Science ®Google Scholar
• Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjørbaek C, Flier JS. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004; 10:734 - 8; http://dx.doi.org/10.1038/nm1072; PMID: 15220914
   PubMed Web of Science ®Google Scholar
• Kievit P, Howard JK, Badman MK, Balthasar N, Coppari R, Mori H, et al. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab 2006; 4:123 - 32; http://dx.doi.org/10.1016/j.cmet.2006.06.010; PMID: 16890540
   PubMed Web of Science ®Google Scholar
• Zhang R, Dhillon H, Yin H, Yoshimura A, Lowell BB, Maratos-Flier E, et al. Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology 2008; 149:5654 - 61; http://dx.doi.org/10.1210/en.2008-0805; PMID: 18669597
   PubMed Web of Science ®Google Scholar
• Olofsson LE, Unger EK, Cheung CC, Xu AW. Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance. Proc Natl Acad Sci U S A 2013; 110:E697 - 706; http://dx.doi.org/10.1073/pnas.1218284110; PMID: 23386726
   PubMedGoogle Scholar
• Matarazzo V, Schaller F, Nédélec E, Benani A, Pénicaud L, Muscatelli F, et al. Inactivation of Socs3 in the hypothalamus enhances the hindbrain response to endogenous satiety signals via oxytocin signaling. J Neurosci 2012; 32:17097 - 107; http://dx.doi.org/10.1523/JNEUROSCI.1669-12.2012; PMID: 23197703
   PubMed Web of Science ®Google Scholar
• Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard JP, et al. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 2004; 53:2232 - 41; http://dx.doi.org/10.2337/diabetes.53.9.2232; PMID: 15331532
   PubMed Web of Science ®Google Scholar
• Jorgensen SB, O’Neill HM, Sylow L, Honeyman J, Hewitt KA, Palanivel R, et al. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes 2013; 62:56 - 64; http://dx.doi.org/10.2337/db12-0443; PMID: 22961088
   PubMed Web of Science ®Google Scholar
• Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006; 12:829 - 34; http://dx.doi.org/10.1038/nm1425; PMID: 16783372
   PubMed Web of Science ®Google Scholar
• Emery B, Cate HS, Marriott M, Merson T, Binder MD, Snell C, et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc Natl Acad Sci U S A 2006; 103:7859 - 64; http://dx.doi.org/10.1073/pnas.0602574103; PMID: 16682639
   PubMed Web of Science ®Google Scholar
• Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994; 120:143 - 53; PMID: 8119123
   PubMed Web of Science ®Google Scholar
• Smith PD, Sun F, Park KK, Cai B, Wang C, Kuwako K, et al. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 2009; 64:617 - 23; http://dx.doi.org/10.1016/j.neuron.2009.11.021; PMID: 20005819
   PubMed Web of Science ®Google Scholar
• Sun F, Park KK, Belin S, Wang D, Lu T, Chen G, et al. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011; 480:372 - 5; http://dx.doi.org/10.1038/nature10594; PMID: 22056987
   PubMed Web of Science ®Google Scholar